Correctors of Delta F508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein

*Department of Biochemistry and Biophysics.
The FASEB Journal (Impact Factor: 5.48). 10/2012; 27(2). DOI: 10.1096/fj.12-216119
Source: PubMed

ABSTRACT Most cystic fibrosis is caused by the deletion of a single amino acid (F508) from CFTR and the resulting misfolding and destabilization of the protein. Compounds identified by high-throughput screening to improve ΔF508 CFTR maturation have already entered clinical trials, and it is important to understand their mechanisms of action to further improve their efficacy. Here, we showed that several of these compounds, including the investigational drug VX-809, caused a much greater increase (5- to 10-fold) in maturation at 27 than at 37°C (<2-fold), and the mature product remained short-lived (T(1/2)∼4.5 h) and thermally unstable, even though its overall conformational state was similar to wild type, as judged by resistance to proteolysis and interdomain cross-linking. Consistent with its inability to restore thermodynamic stability, VX-809 stimulated maturation 2-5-fold beyond that caused by several different stabilizing modifications of NBD1 and the NBD1/CL4 interface. The compound also promoted maturation of several disease-associated processing mutants on the CL4 side of this interface. Although these effects may reflect an interaction of VX-809 with this interface, an interpretation supported by computational docking, it also rescued maturation of mutants in other cytoplasmic loops, either by allosteric effects or via additional sites of action. In addition to revealing the capabilities and some of the limitations of this important investigational drug, these findings clearly demonstrate that ΔF508 CFTR can be completely assembled and evade cellular quality control systems, while remaining thermodynamically unstable. He, L., Kota, P., Aleksandrov, A. A., Cui, L., Jensen, T., Dokholyan, N. V., Riordan, J. R. Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: CFTR is a cAMP-activated chloride and bicarbonate channel that is critical for lung homeostasis. Decreases in CFTR expression have dire consequences in cystic fibrosis (CF) and have been suggested to be a component of the lung pathology in Chronic Obstructive Pulmonary Disease (COPD). Decreases or loss of channel function often lead to mucus stasis, chronic bacterial infections, and the accompanying chronic inflammatory responses that promote progressive lung destruction, and eventually in CF, lung failure. Here we discuss CFTR's functional role airway surface liquid hydration and pH, in regulation of other channels such as the epithelial sodium channel, and in regulating inflammatory responses in the lung.
    AJP Lung Cellular and Molecular Physiology 11/2014; DOI:10.1152/ajplung.00326.2014 · 4.04 Impact Factor
  • Pharmacogenetics and Genomics 01/2015; 25(3):149-156. DOI:10.1097/FPC.0000000000000112 · 3.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The major Cystic Fibrosis causing mutation, F508del-CFTR, impairs biosynthetic maturation of the CFTR protein, limiting its expression as a phosphorylation dependent channel on the cell surface. The maturation defect can be partially rescued by low temperature (27°C) cell culture conditions or small molecule corrector compounds. Following its partial rescue, the open probability of F508del-CFTR is enhanced by the potentiator compound, VX-770. However, the channel activity of rescued F508del-CFTR remains less than that of the Wt-CFTR protein in the presence of VX-770. In this study, we asked if there are allosteric effects of F508del on the phosphorylation regulated R domain. To identify defects in the R domain, we compared the phosphorylation status at PKA sites in the R domain of Wt and F508del-CFTR. Here we show that phosphorylation of Ser-660, quantified by selected reaction monitoring-mass spectrometry (SRM-MS), is reduced in F508del-CFTR. Although the generation of a phospho-mimic at this site (substituting aspartic acid for serine) did not modify the maturation defect, it did enhance F508del-CFTR channel function after pharmacological rescue with corrector VX-809, and treatment with the potentiator, VX-770. These findings support the concept that defective phosphorylation of F508del-CFTR partially accounts for its altered channel activity at the cell surface.This article is protected by copyright. All rights reserved
    Proteomics 01/2015; 15(2-3). DOI:10.1002/pmic.201400218 · 3.97 Impact Factor


Available from
Jan 7, 2015